8-K - Arcadia Biosciences, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Arcadia Biosciences dismissed Deloitte as its independent auditor and engaged RJI as its new auditor effective March 30, 2026, with clean audit reports except for going concern qualification.

Key Takeaways

1Audit Committee dismissed Deloitte on March 30, 2026.

2Deloitte's reports for 2024 and 2025 had no adverse opinions except going concern explanatory paragraph.

3No disagreements with Deloitte during two fiscal years and interim period through March 30, 2026.

4Engaged RJI effective immediately as new auditor for Q1 2026 review and 2026 audit.

5No prior consultations with RJI on accounting or audit matters.

6Deloitte agrees with Item 4.01(a) disclosures but has no basis for 4.01(b).

Current Report Details

Event Type

Auditor Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

4.01

and, if not, stating the respects in which it does not agree. A letter from Deloitte is attached hereto as Exhibit 16.1. (b) Engagement of New Independent Regis

Auditor Change

9.01

Financial Statements and Exhibits. (d) Exhibits | Exhibit No. | | Description | |---|---|---| | 16.1 | | Letter from Deloitte & Touche LLP to the Securities and

Exhibits Only

Exhibits (2)

16.1

EX-16.1

8-K